Women who use Depo-Provera face a higher risk of developing a slow-growing brain tumor, known as a meningioma, while the ...

Meningiomas are the most common brain tumors in adults, accounting for 38% to 42% of all primary central nervous system ...

For decades, millions of women have relied on the Depo-Provera birth control shot as a convenient form of long-term contraception. However, growing medical evidence has linked long-term Depo-Provera ...

In recent years, several major medical studies have identified a potential association between the Depo-Provera birth control shot and the development of meningioma brain tumors. Meningioma is ...

Depot medroxyprogesterone acetate use was tied to higher meningioma risk in a large U.S. study. Other contraceptives, including IUDs and combined oral pills, showed no increased meningioma risk.

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Using the progestogen-only contractive pill "desogestrel" for more than ...

The Food and Drug Administration approved on Friday a label change for Pfizer's birth control shot Depo-Provera that warns patients of the risk of meningioma, a tumor in the lining of the brain.